News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Hot topic

REGULATION
China Requires Drug Market Authorization Holders to Submit Annual Report
On Dec. 10, 2020, the National Medical Products Administration (NMPA) published the drafts of Administrative Provisions of Annual Drug Reports and Template for the Annual Drug Report, asking for public consultation before Dec. 22, 2020.
Mar 08, 2021

REGULATION
Most Popular
- [Updated] China Publishes the Preliminary List of Drugs for 2023 National Reimbursement Drug List (NRDL)
- [Updated] Biopharma Licensing Deals Involving Chinese Companies in H1 2023
- Drug Inspections of Manufacturers and Suppliers in China: Regulation Revised
- [Updated] GLP-1-RAs Swoop to Chinese Market, Eyeing Diabetes Treatment & Weight Control Needs
- Monthly Report: New Drug Approvals in China | July 2023
